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Traceless synthesis of protein thioesters using enzyme-mediated 
hydrazinolysis and subsequent self-editing of cysteinyl prolyl 
sequence 
 Chiaki Komiya,a Akira Shigenaga,*a Jun Tsukimoto,b Masahiro Ueda,a Takuya Morisaki,a Tsubasa 
Inokuma,a Kohji Itohb and Akira Otaka*a 
A traceless thioester-producing protocol featuring 
carboxypeptidase Y-mediated hydrazinolysis of cysteinyl prolyl 
leucine-tagged peptides has been developed. The hydrazinolysis 
followed by thioesterification affords cysteinyl prolyl thioesters. 
Self-editing of the tag and subsequent trans-thioesterification 
yields peptide thioesters. The developed protocol was successfully 
applied to conversion of recombinant proteins to thioesters.  
Proteins possessing various modifications or unnatural amino 
acids have served as molecular probes in the investigation of 
the biological significance of proteins. Access to such proteins is 
achieved mainly by native chemical ligation (NCL) with 
peptide/protein thioesters as key synthetic intermediates.1–3 
Because NCL produces proteins via a chemoselective amide 
forming reaction between a thioester and N-terminal cysteine 
units, protein thioesters available from expressed proteins 
could function as indispensable intermediates in the 
preparation of semi-synthetic proteins.3 Among semi-synthetic 
protocols using recombinant-protein-derived thioesters, 
expressed protein ligation has gained wide popularity.4 This 
technique features the use of intein-fused recombinant 
proteins for production of the requisite thioesters. Such intein-
fused proteins produce protein thioesters by the action of intein 
as a self-processing element. Application of the intein-mediated 
protocol however, does not always produce the desired 
thioesters efficiently. This is due partly to incomplete folding or 
the less soluble nature of some intein fusions.5 Thus, other 
recombinant protein-compatible protocols are highly desired. 
Transpeptidase-mediated methods using sortase A (SrtA)6 or 
butelase 17 were developed as alternative protocols and have 
enjoyed success in producing thioesters. A potential limitation 
of these protocols is that enzyme-recognizing sequences 
required for trans-peptidylation remain in the resulting 
thioesters. Consequently, a traceless synthesis of protein 
thioesters has been required.8 In this context, we focused on 
carboxypeptidase Y (CPaseY) (EC 3.4.16.5),9 which is easily 
obtained from commercial sources or baker’s yeast,10 for C-
terminal selective thioesterification of an appropriate 
recombinant protein. CPaseY, a serine protease, exhibits 
exopeptidase activity and can hydrolyze a peptide bond at the 
C-terminal end of a peptide or protein through an O-acyl
enzyme intermediate. Instead of hydrolysis of the O-acyl
enzyme intermediate affording peptide/protein acids, it was
envisioned that hydrazinolysis of the intermediate could yield a
peptide/protein hydrazide which works as a thioester precursor
via the corresponding acyl azide.11,12 Herein, we report a novel
traceless thioester-producing system using the CPaseY-
mediated hydrazinolysis of a C-terminal tagged peptide.
Initially, we attempted the CPaseY-mediated hydrazinolysis of a
model peptide (1) in the presence of hydrazine in aqueous
solution (Figure 1A). Although the desired peptide hydrazide (2)
was observed in the reaction, over-reaction products (3, 4) were
generated (Figure 1B).
Figure 1. (A) CPaseY-mediated digestion of model peptide 1 in the presence of 
hydrazine; (B) HPLC monitoring of CPY-mediated hydrazinolysis. HPLC conditions: 
see Table S2 in ESI. 
a. Institute of Biomedical Sciences and Graduate School of Pharmaceutical Sciences, 
Tokushima University; Tokushima 770-8505, Japan, E-mail: aotaka@tokushima-
u.ac.jp (A.O.); shigenaga.akira@tokushima-u.ac.jp (A.S.)
b. Institute of Medicinal Resources, Graduate School of Pharmaceutical Sciences, 
Tokushima University; Tokushima 770-8505, Japan
Electronic Supplementary Information (ESI) available: See DOI: 10.1039/x0xx00000x
This is an Accepted Manuscript of an article published by The Royal Society of Chemistry in Chemical Communications,
 available online: https://doi.org/10.1039/C9CC03583D
COMMUNICATION Journal Name 
2  |  J. Name. , 2012, 00,  1-3  This journal is © The Royal Society of Chemistry 20xx 
Please do not adjust margins 
Please do not adjust margins 
 
Figure 2. (A) Suppression of over-reaction by the use of substrate preference of 
CPaseY in the presence of cyclohexanone; (B) HPLC monitoring of CPaseY-
mediated hydrazinolysis of peptide 5. HPLC conditions: see ESI. 
This result is consistent with the fact that CPaseY also 
hydrolyzes C-terminal amide peptides.13,14 Applicability of other 
nucleophiles, including thiols, to the CPaseY-mediated reaction 
was examined, but attempts failed to yield the desired products 
(Table S3 in ESI). We next attempted to suppress further 
degradation of the resulting hydrazide (2) by hydrazone 
formation using carbonyl compounds (Figure S1 in ESI). 
Although cyclohexanone suppresses the CPaseY-induced over-
reaction with the yield of 2 approaching 70%, no further 
significant improvement of the yield by tuning the reaction 
conditions including the use of aniline catalyst15 was achieved. 
We next examined the applicability of the substrate preference 
of CPaseY to suppression of the over-reaction. CPaseY shows 
strong preference for hydrophobic amino acids as the C-
terminal residue with such residues being quickly cleaved.16 On 
the other hand, hydrophilic and prolyl residues are disfavored 
and are removed slowly. We reasoned that a peptide possessing 
a C-terminal “–(disfavored amino acid)–(favored amino acid)–
OH” sequence should resist the CPaseY-induced over-reaction 
to yield the corresponding C-terminal disfavored amino acyl 
hydrazide peptide preferentially. To test this hypothesis, Ac-
ALYGPL-OH (5) (1.0 mM), which has Pro and Leu as disfavored 
and favored residues, respectively, was subjected to the 
hydrazinolysis protocol (2.4 μM CPaseY, 2 M NH2NH2·H2O, 50 
mM cyclohexanone, pH 8.0, 25 °C) as shown in Figure 2A. After 
a 12 h reaction of 5, the desired Ac-ALYGP-NHNH2 (6) was 
formed as the major product (Figure 2B). Proline was proven to 
be the best choice for the disfavored residue because the 
reaction of Ac-ALYGXL-OH (X = R or K) under the 
aforementioned conditions produced over-reaction products 
(Figure S2 in ESI). The resulting hydrazide (6) should be 
efficiently converted to the corresponding prolyl thioester via 
the peptidyl azide according to Liu’s protocol.12 However, the 
sequence of reactions affords only the prolyl thioester which is 
not a versatile thioester in the standard NCL protocol.17 
Consequently, we next examined the conversion of the prolyl 
thioester to other amino acyl thioesters.Our previous research 
concerned the use of the prolyl thioesters under a specific NCL 
conditions optimized for the prolyl thioesters. NCL of a prolyl 
thioester peptide tended to produce two-residue (Xaa-Pro)-
deleted ligation products, by diketopiperazine formation.18 The 
cysteinyl prolyl ester (CPE) system was developed by Kawakami 
and Aimoto19 for preparation of peptide thioesters. Under 
weakly basic conditions (pH > 7.8), CPE peptides (-XaaCysPro-
OR) are converted to thioesters (-Xaa-SR) via its self-editing 
through an N–S acyl transfer followed by diketopiperazine 
formation. We envisioned that an amino acyl cysteinyl prolyl 
thioester (-XaaCysPro-SR) resulting from the hydrazinolysis of a 
C-terminal CysProLeu-OH-tagged peptide (-XaaCysProLeu-OH), 
followed by thioesterfication, should be converted to the Xaa 




Scheme 1. Envisioned strategy for synthesis of thioester other than prolyl 
thioester. 
In order to confirm the versatility of such a protocol in 
preparation of proteogenic amino acid thioesters, conversion of 
a model -XaaCysPro-SR peptide to the corresponding Xaa-SR 
peptide followed by NCL was conducted. A model peptide, H–
LYRAACP–NHNH2, (1.0 mM) (7) was treated with NaNO2 in 6 M 
guanidine·HCl–50 mM Na phosphate (pH 3.0) at -10 °C for 30 
min and then the reaction was followed by the addition of 4-
mercaptophenylacetic acid (MPAA) and an N-terminal cysteinyl 
peptide (8) (pH 6.5) (Figure 3). After 3 min of the addition, three 
types of possible thioesters including 9 (-AlaCysPro-SAr: Ar = -
C6H4CH2COOH), 10 (-Ala-SDKP: SDKP = cysteinyl prolyl 
diketopiperazine) and 11 (-Ala-SAr) as the major thioester were 
detected. After 12 h reaction, the thioester (11 (or 10)) 
underwent NCL with 8 to afford the ligated peptide (12) as 
shown in Figure 3B. Although the conversion of prolyl ester in 
the CPE system to the thioester requires weakly basic 
conditions (pH > 7.8),19 the prolyl thioester (9) was converted to 
the thioester (11) under slightly acidic conditions without any 
accompanying hydrolysis products. This result clearly indicates 
that the C-terminal-XaaCysPro-NHNH2 peptides function as 
precursors to the Xaa-SR peptide. 
Thus, we optimized the reaction conditions for efficient 
formation of the -XaaCysPro-NHNH2 peptide. As summarized in 
Table S6 in ESI, a C-terminally CysProLeu-OH-tagged model 
peptide H-LYRAACPL-OH (13a) was subjected to the 
hydrazinolysis reaction under various reaction conditions 
(concentration of CPaseY, hydrazine and cyclohexanone and 
pH). On the basis of these results, the reaction conditions shown 
in entry 3 in Table S6 (1.2 μM CPaseY in the presence of 0.2 M 
NH2NH2·H2O, 60 mM cyclohexanone, pH 6.4, at 25 °C) were 
tentatively adopted as optimal. We then re-evaluated the 
effectiveness of carbonyl compounds in suppression of the 
over-reaction as summarized in Table S7 in ESI. Some carbonyl 
compounds clearly suppressed the over-reaction and 
cyclohexanone was the most effective and economical additive 
among carbonyl compounds examined. 
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Figure 3. (A) Scheme for the conversion of model hydrazide (7) to thioesters and 
subsequent NCL with N-terminal cysteinyl peptide (8). (B) HPLC monitoring of the 
sequence of reactions (after 3 min of addition of 8 (above); after 12 h of the 
addition (below)). HPLC conditions: see Table S4 in ESI. *Non-peptidic impurity. 
**MPAA. 
 
Finally, we attempted to fix the C-terminal amino acid by 
subjecting model peptides H-LYRAACPX-OH, (X = various amino 
acids) (13) to the tentative optimal conditions (Table S8 in ESI). 
Peptides possessing C-terminal hydrophobic residues such as 
Met, Leu, Ile, Val and Ala were converted to the corresponding 
prolyl hydrazide (7) with less than 5% of accompanying over-
reaction products. On the other hand, hydrophilic and aromatic 
residues, especially Trp, were not suitable as the C-terminal 
amino acid. We therefore decided that treatment of the C-
terminally CysProLeu-OH-tagged substrate (1.0 mM) with 1.2 
μM CPaseY in the presence of 0.2 M NH2NH2·H2O and 60 mM 
cyclohexanone, pH 6.4, at 25 °C represents the optimal reaction 
conditions. 
With the conditions established for the conversion of the 
CysProLeu-OH-tagged substrate to the corresponding -CysPro-
NHNH2 peptide, the applicability to various amino acids 
adjacent to the CysProLeu-tag was evaluated by the treatment 
of substrates H-LYRAXCPL-OH, (X = various amino acids) (14). All 
the peptides (14) examined were converted to the 
corresponding hydrazides H-LYRAXCP-NHNH2 (15) with >90% 
conversion (Table 1, entries 1–9, 11–19). Although the reaction 
of peptides possessing hydrophobic amino acids was 
accompanied by over-reaction products, employment of a 
reduced quantity of CPaseY suppressed the over-reaction 
(entries 15–19). These phenomena can be explained by the fact 
that CPaseY has a deep hydrophobic recognition cavity which 
accepts a C-terminal region of up to five residues.20 Because NCL 
of the Asp thioester is known to afford a mixture of α- and -
peptides, we did not examine the application to Asp (entry 
10).21 All obtained hydrazides (15 or 7) were shown to function 
as precursors of thioesters H-LYRAX-SAr (16) yielding the 
corresponding ligated products (17 or 12) via NCL with H-
CFGRK-NH2 (8). Next, we applied the developed protocol to 
practical peptide synthesis and protein modification. 
Table 1. Application to preparation of various amino acyl thioester. 
 
Entry X 










1 Ala (13a) 1 >97 1 >97 
2 Gly (14a) 1 >97 1 >97 
3 Arg (14b) 3 >97 3 >97 
4 Lys (14c) 6 >97 3 91 
5 His (14d) 3 >97 3 >97 
6 Ser (14e) 3 >97 3 91 
7 Thr 14f) 1 92 12 94 
8 Cys (14g) 1 94 6 83 
9 Asn (14h) 1 >97 3 >97 
10c Asp – – – – 
11 Gln (14i) 1 >97 6 94 
12 Glu (14j) 3 >97 3 80 
13 Met (14k) 1 94 3 94 
14 Trp (14l) 1 95 6 >97 
15d Tyr (14m) 1 94 3 96 
16d Phe (14n) 1 >97 1 >97 
17e Leu (14o) 1 94 12 96 
18e Ile (14p) 1 90 24 81 
19e Val (14q) 1 93 24 92 
a Reactions of steps 1 and 2: see sections 5-2 and 5-3 in ESI. b See section 5-2 
and 5-3 in ESI. c Not attempted. d CPaseY (0.3 μM) was used. e CPaseY (0.1 μM) 
was used and NCL was conducted at 37 ˚C. 
Chemical synthesis of the reduced form of 53-residue C-type 
natriuretic peptide 53 (CNP53 (S3))22 was attempted by NCL of 
the 36-residue thioester (S4) corresponding to CNP (1-36) with 
the 17-residue N-terminal cysteinyl peptide (S5) (Figure S3 in 
ESI). The CysProLeu-OH-tagged 39-residue peptide (S6) was 
synthesized by Fmoc SPPS. Treatment of S6 with CPaseY in the 
presence of NH2NH2 and cyclohexanone gave the 38-residue 
prolyl hydrazide peptide (S7) in 70% isolated yield (Figure S3B in 
ESI). The thioesterification of S7 followed by NCL with S5 yielded 
the desired S3 in 88% isolated yield (Figure S3C in ESI). 
Success in the synthesis of CNP53 prompted us to examine the 
chemical modification of expressed proteins (Figure 4A). As a 
model expressed protein, we used the 229-residue glutathione 
S-transferase (GST) protein.23 The CysProLeu-OH-tagged 232-
residue GST (18) was expressed and the resulting protein was 
converted to the C-terminal prolyl hydrazide protein (19). Then, 
conversion of 19 to GST thioester followed by NCL with a 
biotinylated peptide (20) yielded the biotinylated protein (21). 
A newly formed band showed the biotinylated signal by 
Western blotting using streptavidin-HRP (Figure 4B). The over-
all conversion was estimated by Coomassie Brilliant Blue (CBB) 
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stained gel analysis to be about 70%. The generality of the 
developed protocol was further confirmed by successful 
chemical modification of DsRED-express protein (S8 in ESI, 















Figure 4. (A)Scheme for the application of CPY-mediated protocol to C-terminally 
CysProLeu-OH-tagged recombinant GST protein (18); (B) SDS-page analysis of 
protein samples 
Conclusions 
A traceless thioester-producing protocol applicable to naturally 
occurring sequences has been developed. The protocol features 
a sequence of enzymatic and chemical reactions. The enzymatic 
reaction of C-terminally CysProLeu-OH-tagged peptides with 
CPaseY in the presence of NH2NH2 and cyclohexanone affords 
the -CysPro-NHNH2 peptides. Chemical conversion of the 
hydrazide to -CysPro-SR results in the formation of various 
peptide thioesters via self-editing process. Chemical 
modification of recombinant proteins is also achieved with the 
developed protocol. 
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All commercial reagents were used without further purification. CPaseYS1 was purchased from 
Worthington Industries. CPaseY was stored as 0.5 mg/mL (7.7 M) of aqueous solution (pure 
water) at –78 °C. Each peptide or protein was characterized by MS analyses as mentioned below. 
Mass spectra (for peptide samples) were recorded on Waters MICROMASS® LCT 
PREMIERTM by electrospray ionization time-of-flight (ESI-TOF) reflection experiments or 
LC-MS (Shimadzu, Japan, Prominence-I LC-2030, LCMS-2020, a Cosmosil 5C18-AR-II 
analytical column (Nacalai Tesque, Japan, 4.6×250 mm, flow rate 1 mL min−1, eluting products 
were detected by UV at 250 nm and MS). ESI mass spectra (for protein samples) were obtained 
using a QTOF mass spectrometer, which is a hybrid quadrupole orthogonal acceleration tandem 
mass spectrometer fitted with a Z-sprayTM nanoflow electrospray ion source (Waters, MA). 
Samples were dissolved in 0.3 % aqueous formic acid/acetonitrile (1:1, v/v) at the concentration 
of 20 pmol/L, and loaded into a borosilicate nanoflow tip (Thermo Fisher Scientific, MA). 
Calibration was performed using cluster ions derived from NaI as the external standard, and 
allowed for the measurements with a mass accuracy of about 50 ppm. MS data were processed 
by the maximum entropy data enhancement program, MaxEnt 1TM (Waters), which is capable 
of deconvoluting a spectrum with peaks in a variety of charge states to the singly charge-state 
spectrum. For HPLC separation, Cosmosil 5C18-AR-II analytical column (Nacalai Tesque, 4.6 
× 250 mm, flow rate 1.0 mL/min), Cosmosil 5C18-AR-II semi-preparative column (Nacalai 
Tesque, 10 × 250 mm, flow rate 3.0 mL/min), or Cosmosil 5C18-AR-II preparative column 
(Nacalai Tesque, 20 × 250 mm, flow rate 10.0 mL/min). was employed, and eluting products 
were detected by UV at 220 nm. A solvent system consisting of 0.1% TFA aqueous solution 






1. General Procedure for Peptide Synthesis 
 
Unless otherwise noted, peptides used in this work were synthesized by Fmoc solid-phase 
peptide synthesis (Fmoc SPPS) on NovaSyn® TGR resin (Rink amide type: 0.25 mmol amine/g), 
Rink Amide AM resin (0.62 mmol amine/g), Wang resin (0.80 mmol alcohol/g) or HMPB-
ChemMatrix resin (0.5 mmol alcohol/g). Fmoc SPPS was performed according to the following 
protocol. 
1. Removal of Fmoc groups was carried out using 20% (v/v) piperidine in DMF for 10 min 
at room temperature. 
2. The resin was washed with DMF (10 times) 
3. A standard Fmoc-protected amino acid (4 equiv.) was coupled with the aid of N,N-
diisopropylcarbodiimide (DIPCI) (4 equiv.) and 1-hydroxybenzotriazole monohydrate 
(HOBt·H2O) (4 equiv.) or N,N-diisopropylethylamine (DIPEA) (4.0 equiv.) and 
N,N,N’,N’-tetramethyl-O-(benzotriazole-1-yl)uronium hexafluorophosphate (HBTU, 
3.9 equiv.) in DMF for 1.5 h. Completion of the coupling reaction was checked by the 
Kaiser ninhydrin test. The coupling reaction was repeated until the Kaiser test became 
negative. 
4. The resin was washed with DMF (5 times). 
5. The cycle of steps 1 to 4 was repeated. 
 
Deprotection of acid-lable protecting groups with concomitant release of peptides from a resin 
was achieved using a cocktail of TFA-m-cresol-thioanisole-H2O-1,2-ethanedithiol (80:5:5:5:5 
(v/v), 50 μL/1 mg resin) at room temperature for 2 h. The resin was filtered off and the filtrate 
was concentrated by N2 stream. Then cooled diethyl ether (Et2O) was added to the concentrate 
and the formed precipitate was collected by centrifugation. The obtained precipitate was 




2. Attempt of CPaseY-mediated Hydrazinolysis of Peptide Acids (1 and 5) 
 
2-1. Preparation of peptides acids (1 and 5) 
Peptides were synthesized on Fmoc-Ala-O-Wang (for 1) or Fmoc-Leu-O-Wang (for 5) resin 
(see below) by Fmoc SPPS (see general procedure for peptide synthesis). 
Requisite Fmoc-amino acid-loaded resins were prepared as follows. On Wang resin (0.80 
mmol/g), Fmoc-Xaa-OH (10 equiv.) was coupled with the aid of HBTU (9.9 equiv.), DIPEA 
(10 equiv.) and DMAP (0.05 equiv.) in DMF at room temperature for 3 h. The resulting resin 
was treated with Ac2O (10 equiv.) and pyridine (10 equiv.) in DMF at room temperature for 30 
min to mask the unreacted hydroxyl groups with Ac group. After the capping, the loading of 
Xaa was checked by quantification of the Fmoc group. Using Fmoc-Xaa resins, peptide acids 
(1 and 5) were synthesized as mentioned above. Characterization data of synthetic peptides are 
shown in Table S1. 
 















Gradient (%) Calcd Found 
1 20.4 1–40 13–23 607.3 [M + H]+ 607.2 45 





2-2. Initial attempt of CPaseY-mediated hydrazinolysis of peptide acid (1) 
Peptide substrate Ac-ALYGAA-OH (1) (0.050 μmol) was incubated in 250 μL of aqueous 
solution containing 30 nM CPaseY and 2 M NH2NH2·H2O (pH 8.0) at 25 ˚C for 12 h. The 
reaction was monitored and analyzed by HPLC. Before analysis, the reaction solution was 
diluted two-fold by quenching buffera and incubated at 37 ˚C for 10 min. Data of the resulting 
peptides including over-reaction products from reaction are summarized in Table S2. 
aQuenching buffer: 50 mM Na phosphate, 100 mM TCEP, pH 6.8. 
 












2-3. Attempt of the direct conversion of peptide substrate (1) to the corresponding 
thioester 
For the attempt of the direct conversion to the thioester, 1 (0.050 μmol) was incubated in 250 
μL of 50 mM HEPES buffer containing 100 nM CPaseY and 1 M sodium 2-
mercaptoethanesulfonate (MESNa) (pH 6.0, 7.0 and 8.0) at 25 ˚C for 24 h. And the attempted 
reactions were monitored and analyzed by HPLC. Before analysis, the reaction solution was 
diluted two-fold by quenching buffera and incubated at 37 ˚C for 10 min. Furthermore, other 
nucleophiles indicated in Table S3 were also examined. Results are summarized in Table S3. 
aThe quenching buffer: 50 mM Na phosphate, 100 mM TCEP, pH 6.8. 
 
















Analytical HPLCa m/z 
Retention time (min) Calcd Found 
Ac-ALYGAA-OH (1) 20.5 607.3 [M + H]+ 607.4 
Ac-ALYGA-NHNH2 (2) 17.8 550.3 [M + H]+ 550.3 
Ac-ALYG-NHNH2 (3a) 17.5 479.3 [M + H]+ 479.4 
Ac-ALYG-OH (3b) 19.4 465.2 [M + H]+ 465.4 
Ac-ALY-NHNH2 (4a) 17.5 422.2 [M + H]
+ 422.2 
Ac-ALYGA-OHb  19.4 536.3 [M + H]+ 536.3 
aCosmosil 5C18-AR-II analytical column was employed with a linear gradient of solvent B in solvent A over 30 
min.;  HPLC conditions: a linear gradient of 0.1% TFA-MeCN (1–40% over 30 min) in 0.1 % TFA aq. bTrace amount 
of hydorolysis product of 1 was detected. 
Entry CPaseY 
(nM) 
Nucleophile X = Nu (%) X = OH (%) 
1 100 MESNa (pH 6.0) 0 100 
2 100 MESNa (pH 7.0) 0 100 
3 100 MESNa (pH 8.0) 0 100 
4 60 NH2NH2·H2O 84 16 
5 60 NH2NHMe 62 38 
6 60 NH2NMe2 26 74 
7 60 NH2OH 29 70 





2-4. Suppression of the over-reactions by the addition of cyclohexanone 
To suppress the CPaseY-mediated over-reaction, 1 (0.050 μmol) was incubated in 250 μL of 
aqueous solution containing 30 nM CPaseY, 2 M NH2NH2·H2O and 50 mM cyclohexanone (pH 
8.0) at 25 ˚C for 12 h. The reaction was monitored and analyzed by HPLC. Before analysis, the 
reaction solution was diluted two-fold by quenching buffera and incubated at 37 ˚C for 10 min. 
aThe quenching buffer: 50 mM Na phosphate, 200 mM MeONH2·HCl, 100 mM TCEP, pH 6.8. 





Figure S1. Suppression of over-reaction with cyclohexanone by formation of hydrazone. aYield (%) was 
determined by HPLC separation of product 2 (integ. 2) as a fraction of the sum of remaining substrate 1 (integ. 1) 
+ over-reaction products (integ. over) + integ. 2. 
 
 
2-5. CPaseY-mediated hydrazinolysis of peptide 5 and other C-terminal –XaaLeu-OH 
(Xaa = Arg (S1) or Lys(S2)) 
Ac-ALYGPL-OH (5) (0.050 μmol) was incubated in 50 μL of aqueous solution containing 2.4 
μM CPaseY and 2 M NH2NH2·H2O with 50 mM cyclohexanone (pH 8.0) at 25 ˚C for 12 h. The 
reaction was monitored and analyzed by LC-MS. Before analysis, the reaction solution was 
diluted two-fold by quenching buffera and incubated at 37 ˚C for 10 min. Ac-ALYGP-NHNH2 
(6): retention time = 15.8 min (analytical HPLC conditions: linear gradient of solvent B in 
solvent A, 5–40% over 30 min); The observed m/z was 576.2 (calculated m/z: 576.3 [M + H]+). 
aThe quenching buffer: 50 mM Na phosphate, 200 mM MeONH2·HCl, 100 mM TCEP, pH 6.8. 
 
Ac-ALYGXL-OH (S1 (X = R) and S2 (X = K)) was subjected to CPaseY-mediated 

























Figure S2. CPaseY-mediated hydrazinolysis of C-terminal -XaaLeu-OH peptide 
 
3. CPE-like Thioesterification of Peptide Hydrazide (7) and Subsequent NCL with 
N-Terminal Cys Peptide (8) 
 
3-1. Synthesis of peptide hydrazide (7) and N-terminal Cys peptide (8) 
H-LYRAACP-NHNH2 (7) was synthesized on hydrazine 2-Cl Trt resin by Fmoc SPPS (see 
general methods). The hydrazine 2-Cl Trt resin was prepared according to the protocol 
described by Liu. LC-MS conditions: A linear gradient of solvent B in solvent A, 5–35% over 
30 min, retention time = 14.8 min. Semi-preparative HPLC condtions: A linear gradient of 
solvent B in solvent A, 5–18% over 30 min. MS (ESI-TOF) m/z calcd ([M+H]+) 807.4, found 
807.4. 
H-CFGRK-NH2 (8) was synthesized on NovaSyn
® TGR resin by Fmoc SPPS according to the 
protocol described by Otaka.S2 
 
3-2. Thioesterification of 7 and subsequent NCL with 8S3 
Peptide hydrazide (7) sample obtained by chemical synthesis (mentioned above) or by CPaseY-
mediated protocol (mentioned below) (0.100 μmol) was subjected to NCL with N-terminal Cys 
peptide (8). Experimental procedure was described in the following section (Typical 
experimental procedure for conversion of C-terminally CysProLeu-OH-tagged peptide to the 
corresponding hydrazide followed by the NCL protocol: Page S9). Data of peptides formed in 
the reaction were summarized in Table S4. 
 















Analytical HPLCa m/z 
Retention time (min)  Calcd Found 
7 14.8 807.4 [M + H]+ 807.7 
8 11.0 606.3 [M + H]+ 606.5 
9 26.8 943.4 [M + H]+ 943.6 
10 15.7 775.4 [M + H]+ 775.7 
11 22.8 743.4 [M + H]+ 743.7 
12 17.7 592.4 [M + 2H]2+ 592.5 
aCosmosil 5C18-AR-II analytical column was employed with a linear gradient of solvent B in solvent A over 30 






4. Evaluation of CPaseY-mediated Hydrazinolysis under Several Reaction 
Conditions 
 
4-1. Preparation of C-terminal –CPX–OH substrate peptides (13) 
All peptides were prepared according to the protocol described for preparation of peptide acids 
1 and 5. 
Characterization data of peptides are shown in Table S5. 
 


















4-2. Experiments for optimization, re-evaluation of carbonyl additives, and evaluation of 
influence of the C-terminal amino acids shown in Table S6, S7 and S8 
To optimize the reaction conditions, the concentrations of NH2NH2·H2O, cyclohexanone and 
CPaseY and the pH were separately changed from the standard procedure. HPLC yields were 
summarized in Table S6. 
Standard procedure (Table S6, entry 3): H-LYRAACPL-OH (13a) (0.050 μmol) was incubated 
in 50 μL (1 mM peptide) of aqueous solution of 1.2 μM CPaseY, 0.2 M NH2NH2·H2O, 60 mM 
cyclohexanone, pH 6.4 at 25 ˚C for 1 h. The reaction was monitored and analyzed by LC-MS. 
Before analysis, the reaction solution was diluted two-fold by quenching buffera and incubated  
 at 37 ̊ C for 10 min. aThe quenching buffer: 50 mM Na phosphate, 200 mM MeONH2·HCl, 200 
mM TCEP, pH 6.8. 
To re-evaluate carbonyl compounds as additives for this reaction, each carbonyl compound was 
used instead of cyclohexanone. HPLC yields were summarized in Table S7. 
To evaluate the influence of C-terminal amino acid of substrate, instead of peptide substrate 
(13a), each peptide 13b–k was subjected to the optimal reaction conditions shown in Table S6 
















Gradient (%) Calcd Found 
13a 25.9 5–30 17–24 905.5 [M + H]+ 905.4 52 
13b 22.8 5–30 13–23 923.4 [M + H]+ 923.2 27 
13c 25.5 5–30 15–25 905.5 [M + H]+ 905.6 49 
13d 22.6 5–30 13–23 939.5 [M + H]+ 939.7 57 
13e 18.1 5–30 10–20 863.4 [M + H]+ 863.6 52 
13f 28.2 5–30 16–26 939.5 [M + H]+ 939.7 52 
13g 22.5 5–30 13–23 955.5 [M + H]+ 955.7 61 
13h 28.8 5–30 15–26 978.5 [M + H]+ 978.7 20 
13i 17.2 5–30 8–18 849.4 [M + H]+ 849.6 13 
13j 15.6 5–30 8–18 920.5 [M + H]+ 920.6 36 
13k 17.2 5–30 9–19 907.4 [M + H]+ 907.7 48 
13l 15.3 5–30 8–13 906.4 [M + H]+ 906.6 17 
aCosmosil 5C18-AR-II analytical column and bCosmosil 5C18-AR-II preparative column were employed with a linear 



















1 1.2 1.0 60 6.4 0 >97 
2 1.2 0.5 60 6.4 0 >97 
3 1.2 0.2 60 6.4 0 >97 (76)b 
4 1.2 0.05 60 6.4 0 89 
5 1.2 0.2 90 6.4 0 >97 
6 1.2 0.2 30 6.4 0 93 
7 1.2 0.2 60 7.4 0 >97 
8 1.2 0.2 60 5.4 0 >97 
9 1.2 0.2 60 4.4 0 83 
10 0.1 0.2 60 6.4 39 60 
aYield (%) was determined by HPLC separation and integration of product 7 (integ. 
7) as a fraction of the sum of the remaining 13a (integ. 13) + over-reaction products 
(integ. over) + integ. 7. bIsolated yield. 
 
 
Table S7. Re-evaluation of carbonyl additives for CPaseY-mediated hydrazinolysis 
 
Entry Additive 




1 No 48 52 
2 2-formylpyridine 25 75 
3 3-formylpyridine 54 46 
4 acetone 27 73 
5 isobutylaldehyde 64 36 
6 pivalaldehyde 27 73 
7 3-pentanone 87 13 
8 cyclopentanone 94 6 
9 cyclohexanone 97 3 
10 cycloheptanone 97 3 




13 1,4-cyclohexanedione 76 24 
aYield (%) was determined by HPLC separation and integration of product 7 (integ. 


















1 Leu (13a) 0 >97 <3  
2 Met (13b) 0 >97 <3  
3 Ile (13c) 0 >97 <3  
4 Val (13d) 0 >97 <3  
5 Phe (13e) 0 95 5  
6 Tyr (13f) 4 91 5  
7 Trp (13g) 73 16 11  
8 Gly (13h) 90 9 –b  
9 Lys (13i) 71 29 –b  
10 Asp (13j) 88 12 –b  
11 Asn (13k) 77 23 –b  
aYield (%) was determined by HPLC separation and integration of product 7 
(integ. 7) as a fraction of the sum of the remaining substrate (integ. substrate) 




5. Application to Preparation of Various Amino Acyl Thioester 
 
5-1. Preparation of the C-terminal -XaaCysProLeu-OH peptides (14) 
All peptides were prepared according to the protocol described for preparation of peptide acids 
1 and 5.Characterization data of synthetic peptides are summarized in Table S9 
 
Table S9. Characterization data of synthetic peptides (14). 
Peptide 
(14) Xaa 







Gradient (%) Calcd Found 
14a (Gly) 25.0 5–30 14–24 892.5 [M + H]+ 892.6 39 
14b (Arg) 24.2 5–30 16–26 991.5 [M + H]+ 991.5 44 
14c (Lys) 23.5 5–30 12–22 963.5 [M + H]+ 963.6 35 
14d (His) 23.8 5–30 13–23 972.5 [M + H]+ 971.6 26 
14e (Ser) 25.0 5–30 16–26 922.5 [M + H]+ 922.6 43 
14f (Thr) 25.8 5–30 16–26 936.5 [M + H]+ 936.5 41 
14g (Cys) 27.9 5–30 16–36 938.5 [M + H]+ 938.6 35 
14h (Asn) 24.4 5–30 14–24 949.5 [M + H]+ 949.6 49 
14i (Gln) 25.2 5–30 15–25 963.5 [M + H]+ 963.5 50 
14j (Glu) 26.0 5–30 14–24 964.5 [M + H]+ 964.5 44 
14k (Met) 26.0 5–35 18–28 967.2 [M + H]+ 9675 54 
14l (Trp) 22.4 5–40 22–32 1021.5 [M + H]+ 1021.4 6 
14m (Tyr) 25.2 5–35 16–26 998.5 [M + H]+ 998.5 31 
14n (Phe) 25.5 5–40 22–32 982.5 [M + H] + 982.6 49 
14o (Leu) 27.5 5–35 18–28 948.5 [M + H] + 948.6 52 
14p (Ile) 18.6 5–55 20–30 948.5 [M + H]+ 948.3 42 
14q (Val) 29.2 5–35 18–28 934.5 [M + H]+ 934.7 28 
aCosmosil 5C18-AR-II analytical column bCosmosil 5C18-AR-II preparative column were employed with a linear 






5-2. CPaseY-mediated hydrazinolysis of C-terminal -XaaCysProLeu -OH peptides (14) 
CPaseY-mediated conversion of various substrate peptides (14) to the corresponding hydrazide 
(15) were performed as follows. Each peptide (14) (per 1 mM peptide) was treated with aqueous 
solution containing 1.2 μM CPaseY, 0.2 M NH2NH2·H2O and 60 mM cyclohexanone, pH 6.4 
at 25 ˚C for 1 h. And the yield (%) of 15 was determined by HPLC separation and integration 
of product (integ. product) as a fraction of the sum of the remaining substrate (integ. substrate) 
+ other products derived from substrate (integ. others) + integ. product.The HPLC yields were 
summarized in the column Step 1 of Table 1. Furthermore, characterization data of the obtained 
hydrazide were summarized in Table S10. 
 
5-3. CPE-like thioesterification of peptide hydrazide (15) and subsequent NCL with N-
terminal Cys peptide (8) 
Each peptide hydrazide (15) was subjected to NCL with N-terminal Cys peptide (8) as shown 
in below. Each obtained hydrazide peptide (15) (per 1.5 mM peptide) was treated with 50 mM 
Na phosphate buffer containing 6 M Gn·HCl and 7.5 mM NaNO2, pH 3.0 at -10 ˚C for 30 min. 
Then 50 mM Na phosphate buffer containing 6 M Gn·HCl, 50 mM MPAA and 2.0 mM H-
CFGRK-NH2 (8) was added to the reaction mixture and the pH was adjusted to pH 6.5. the 
reaction mixture was incubated at rt for 12 h. And the yield (%) of 17 was determined by HPLC 
separation and integration of product (integ. product) as a fraction of the sum of the remaining 
substrate (integ. substrate) + other products derived from substrate (integ. others) + integ. 
product. The HPLC yields were summarized in the column Step 2 of Table 1. Data of peptides 
formed in the reaction were summarized in Table S11. 
 
Table S10. Characterization data of obtained peptide hydrazide (15). 
Peptide 
Analytical HPLCa m/z 
Retention time (min) Gradient (%) Calcd Found 
15a (Gly) 14.0 5–30 793.4 [M + H] + 793.5 
15b (Arg) 14.2 5–30 892.5 [M + H] + 892.6 
15c (Lys) 14.0 5–30 864.5 [M + H] + 864.5 
15d (His) 14.2 5–30 873.5 [M + H] + 873.6 
15e (Ser) 14.1 5–30 823.4 [M + H] + 823.4 
15f (Thr) 14.8 5–30 837.4 [M + H] + 837.5 
15g (Cys) 16.5 5–30 839.4 [M + H] + 839.4 
15h (Asn) 13.6 5–30 850.4 [M + H] + 850.6 
15i (Gln) 14.6 5–30 864.4 [M + H] + 864.4 
15j (Glu) 15.2 5–30 865.4 [M + H] + 865.4 
15k (Met) 16.5 5–35 867.4 [M + H] + 867.4 
15l (Trp) 20.5 5–35 922.5 [M + H] + 922.7 
15m (Tyr) 18.2 5–30 899.5 [M + H] + 899.5 
15n (Phe) 19.7 5–35 883.5 [M + H] + 883.6 
15o (Leu) 18.5 5–35 849.5 [M + H] + 849.6 
15p (Ile) 17.4 5–35 849.5 [M + H] + 849.5 
15q (Val) 15.8 5–35 835.5 [M + H] + 835.5 
aCosmosil 5C18-AR-II analytical column was employed with a linear gradient of solvent B in solvent A over 30 min. 
 
 
5-4. Detail experimental procedure for conversion of C-terminally CysProLeu-OH-tagged 
peptides (13a, 14) to the corresponding hydrazides (7, 15) followed by the NCL protocol.  
C-Terminally CysProLeu-OH-tagged peptide substrate (H-LYRAACPL-OH (13a)) (2.0 μmol) 
was incubated in 0.4 mL (5.0 mM peptide) of hydrazinolysis solution [0.3 μM CPaseY, 0.2 M 




solution, aqueous solution containing NH2NH2·H2O (0.2 M) and cyclohexanone (60 mM) was 
prepared and the pH was adjusted to pH 6.4 with 6 M HCl. To the resulting solution was added 
the stock solution of CPaseY in H2O (7.7 M: 0.5 mg protein/mL) (final concentration: 0.3 μM 
CPaseY, 0.2 M NH2NH2·H2O, 60 mM cyclohexanone, pH 6.4). The solution was used for the 
hydrazinolysis reaction. After completion of the reaction, the reaction solution was diluted two-
fold by the quenching buffer (50 mM Na phosphate, 200 mM MeONH2·HCl, 200 mM TCEP, 
pH 6.8) with additional incubation at 37 ˚C for 10 min. The crude material was analyzed by 
LC-MS and purified by semi-preparative HPLC to give the hydrazide (7) (1.2 mg, 1.50 μmol, 
76%). Semi-preparative HPLC conditions: A linear gradient of solvent B in solvent A, 5–18% 
over 30 min. MS (ESI-TOF) m/z calcd for C35H59N12O8S [M+H]
+ 807.4; Found 807.4. The 
resulting hydrazide (7) (0.10 μmol) was dissolved in 65 μL of 50 mM Na phosphate buffer 
containing 6 M Gn·HCl (pH 3.0) and the reaction mixture was stored at -10 ˚C. Then, 2.5 μL 
of 0.2 M NaNO2 aq. was added to the solution and the reaction mixture was stored at -10 ˚C for 
30 min. After that, 33 μL of 50 mM Na phosphate containing 6 M Gn·HCl and 150 mM MPAA 
was added to the mixture, and the pH of the mixed solution was adjusted to pH 6.5 with 1.0 M 
NaOH aq.. To the mixture was added N-terminal cysteinyl peptide (8) (0.20 μmol) and the 
mixed solution was incubated at room temperature for 12 h. Resulting solution was analyzed 
by LC-MS and HPLC yield of NCL products (12) was calculated according to the equation as 
described in section 5-3. ESI-TOF MS, found: 592.5, m/z calcd for m/z [M+2H]2+ 
(C53H88N18O11S): 592.4. HPLC yields of other NCL products (17) were also similarly obtained. 
 
 




















6. Chemical Synthesis of Reduced Form CNP53 (S3) 
 
6-1. Preparation of peptide fragments S5 and S6 
Both peptides were prepared according to the protocol described for the preparation of peptide 
acids 1 and 5. 
Characterization data of peptides are shown in Table S12. 
 
Peptide 
Analytical HPLCa m/z 
Retention time (min) Gradient (%) Calcd Found 
17a (Gly) 17.1 5–35 585.3 [M + 2H]2+ 585.6 
17b (Arg) 16.5 5–35 634.9 [M + 2H]2+ 635.2 
17c (Lys) 16.7 5–35 620.8 [M + 2H]2+ 621.2 
17d (His) 16.3 5–35 625.3 [M + 2H]2+ 625.7 
17e (Ser) 17.4 5–35 600.3 [M + 2H]2+ 600.6 
17f (Thr) 17.9 5–35 607.3 [M + 2H]2+ 607.7 
17g (Cys) 18.9 5–35 608.3 [M + 2H]2+ 608.6 
17h (Asn) 17.2 5–35 613.8 [M + 2H]2+ 614.1 
17i (Gln) 17.5 5–35 620.8 [M + 2H]2+ 621.2 
17j (Glu) 17.8 5–35 621.3 [M + 2H]2+ 621.7 
17k (Met) 20.1 5–35 622.3 [M + 2H]2+ 622.6 
17l (Trp) 20.7 5–40 649.9 [M + 2H]2+ 650.2 
17m (Tyr) 17.5 5–35 638.3 [M + 2H]2+ 638.7 
17n (Phe) 20.3 5–40 630.3 [M + 2H]2+ 630.6 
17o (Leu) 19.1 5–40 613.4 [M + 2H]2+ 613.7 
17p (Ile) 18.7 5–40 613.4 [M + 2H]2+ 613.6 
17q (Val) 17.5 5–40 606.4 [M + 2H]2+ 606.7 



















6-2. CPaseY-mediated hydrazinolysis of C-terminally CysProLeu-tagged peptide (S6) 
Peptide S6 (0.85 μmol) was incubated in 1.0 mL (0.85 mM peptide) of aqueous solution 
containing 0.6 μM CPaseY, 0.2 M NH2NH2·H2O and 60 mM cyclohexanone (pH 6.4) and 
incubated at 25 ˚C for 1 h. After completion of the reaction, the solution was diluted two-fold 
by the quenching buffera. The crude material was analyzed by HPLC and purified by semi-
preparative HPLC to give hydrazide S7 (2.6 mg, 0.60 μmol, 70%). Characterization data of 
peptides are shown in Table S13. 
aThe quenching buffer: 50 mM Na phosphate, 200 mM MeONH2·HCl, 200 mM TCEP, pH 6.8. 
 
6-3. CPE-like Thioesterification followed by NCL using peptide S7 and S5 
 
Figure S3. Preparation of reduced form CNP 53 (S3) using the CPaseY-mediated synthesis of thioester fragment 
(S4) followed by NCL with N-terminal cysteine peptide (S5). (A) Synthetic scheme for the preparation of reduced 
form CNP 53 (S3). (B) CPaseY-mediated hydrazinolysis reaction of the C-terminally CysProLeu-tagged substrate 
(S6) (after 1 h of reaction). (C) NCL of 0.5 mM of in-situ formed thioester (S4) with 1.0 mM of N-terminal 
cysteinyl peptide (S5) (after 4 h of NCL). HPLC conditions: a linear gradient of 0.1% TFA-MeCN (5–35% over 
30 min) in 0.1 % TFA aq. *Non-peptidic impurity. 
Peptide 








Gradient (%) Calcd Found 
S6 22.1 5–35 14–20 547.9 [M + 8H]8+ 547.8 7 
S5 23.9 5–30 22–32 878.9 [M + 2H]2+ 878.7 16 
aCosmosil 5C18-AR-II analytical column and bCosmosil 5C18-AR-II preparative column were employed with a 





Purified hydrazide (S7) (0.60 μmol) was dissolved in 390 μL of 50 mM Na phosphate buffer 
containing 6 M Gn·HCl (pH 3.0) and the reaction mixture was stored at -10 ˚C. Then, 15 μL of 
0.2 M NaNO2 aq. was added to the solution, and the reaction mixture was stored at -10 ˚C for 1 
h. After that, 200 μL of 50 mM Na phosphate containing 6 M Gn·HCl and 150 mM MPAA was 
added to the solution, and the pH of the mixed solution was adjusted to pH 6.5 with 1.0 M 
NaOH aq.. To the mixture was added N-terminal Cys peptide S5 (1.2 μmol) in 600 μL of 50 
mM Na phosphate containing 6 M Gn·HCl and 50 mM MPAA (pH6.5) and the reaction mixture 
was incubated at room temperature for 4 h. The reaction was monitored and analyzed by HPLC. 
Before analysis, the reaction solution was diluted twice with quenching buffera and incubated 
at 37 ˚C for 10 min. After completion of the reaction (4 h), the solution was diluted twice with 
the quenching buffer. The crude material was purified by semi-preparative HPLC to give 
reduced form CNP 53 S3 (3.0 mg, 0.522 μmol, 88%). 
aThe quenching buffer: 6 M Gn·HCl, 50 mM Na phosphate, 100 mM TCEP, pH 6.8. 
 
Table S13. Characterization data of the resulting hydrazide (S7) and reduced form CNP 53 (S3). 
 
7. Application of CPaseY-mediated Protocol to Expressed Proteins 
 
7-1. Expression and purification of recombinant C-terminally tagged GST (18) and 
DsRED-express (S8) 













cDNAs of C-terminally CysProLeu-tagged GST (18) and C-terminally CysProLeu-tagged Ds-
RED-express (S8)S4 were cloned into the pEV3bS5 and the pGEX-2T vectors, respectively 
(pEV3b and PGEX-2T constructs were designed for affording the tagged GST (18) itself and 
GST-tagged DsRED-express fusion (S8), respectively). The expressions of the proteins were 
done by transforming the constructed plasmids in to E. coli Rosetta 2 DE3 (Merck) competent 
cells. The transformed cells were grown in 1 L of LB-ampicillin (+) medium at 37 °C until the 
optical density became 0.6 before the addition of isopropyl-α-D-thiogalactopyranoside(IPTG). 
After 24 h growth at 25 °C in the presence of 0.1 mM IPTG, cells were harvested by 
centrifugation and suspended in phosphate-buffered saline (PBS). The cells were then lysed in 
Peptide 








Gradient (%) Calcd Found 
S7 22.8 5–35 13–23 1070.1 [M+4H]4+ 1070.2 70 
S3 23.9 5–35 14–24 1161.0 [M+5H]5+ 1161.1 88 
aCosmosil 5C18-AR-II analytical column and bCosmosil 5C18-AR-II preparative column were employed with a linear 




PBS (pH 7.4) by sonication, and a supernatant was obtained by centrifugation during which 
Triton X-100 was added to a final concentration of 1%. Each supernatant containing the tagged 
GST (18) or the GST–tagged DsRED-express fusion (S8) proteins was applied to a GSH-
Sepharose (GE Healthcare, Uppsala, Sweden) affinity chromatography column equilibrated 
with PBS (pH 7.4) containing 1% TritonX-100. For the elution of 18, the adsorbed protein was 
eluted with PBS (pH 7.4) containing 20 mM reduced L-glutathione (GSH). The eluted protein 
was concentrated by using centrifugal filters (10000 MW cut off). For the elution of the tagged 
DsRED-express (S8), cleavage of the thrombin-recognition sequence located between the GST 
and tagged DsRED-express (S8) infusion proteins was carried out by adding 1 mL of a thrombin 
solution comprising 1 U/mL in PBS, and then incubating the column for 16 h at 25 °C. The 
eluted S8 was concentrated by using centrifugal filters (10000 MW cut off). 
 
7-2. Application to expressed CysProLeu-OH-tagged GST protein (18). 
Expressed CysProLeu-OH-tagged GST protein (18) (9.7 nmol) was incubated in 90 μL (108 
μM) of aqueous solution containing 1.2 μM CPaseY, 0.2 M NH2NH2·H2O, 60 mM 
cyclohexanone (pH 6.4) at 25 ˚C for 1 h to convert to the CysPro-NHNH2 protein (19). The 
reaction mixture was quenched with 50 mM Na phosphate containing 200 mM DTT, 200 mM 
MeONH2·HCl (90 L). The mixture was incubated at 25 ˚C for 10 min and then buffer-
exchanged, by use of a desalting column and centrifugal filter equipped with a 10 kDa molecular 
weight cut off, into 50 mM Na phosphate (pH 6.8, 120 μL). A part of the protein mixture 
consisting of 18 and 19 (3.0 nmol, 34 μL) was mixed with 4.5 μL of 50 mM Na phosphate 
containing 6 M Gn·HCl and the pH was adjusted to 3.0 with 1 M HCl aq. To the mixture, 25 
mM NaNO2 aq. (4.5 L) was added at 4 ˚C and the reaction mixture was stored at 4 ˚C for 30 
min (75 mM). Then excess biotinylated N-terminal Cys peptideS6 (20) (12 nmol) in 50 mM Na 
phosphate containing 6 M Gn·HCl and 150 mM MPAA (24 L) was added to the reaction 
mixture and the mixture was incubated at rt. Subsequently, the crude proteins including the 
desired biotinylated protein (21) was obtained by trichloroacetic acid (TCA) precipitation to 
remove small molecules. All samples including starting protein (18) was analyzed by SDS-
PAGE (CBB stain and Western blot analysis using streptavidin-HRP) (Row CBB strained gel 
image Fig S4. For Fig. 4, lanes 1–3 were used). Characterization of protein samples was 
performed by ESI-QTOF MS analyses of samples desalted by Protein R HPLC column. The 
conversion yield (~ 70%) was estimated by quantitation of the ligated protein from CBB-stained 
gel image using image J software. C-Terminally CysProLeu-OH-tagged protein (18): ESI-Q-
TOF MS, found: 26623.0, calcd for molecular mass (M) (C1218H1881N305O336S14) 26622.3 
(average). C-Terminal CysPro-NHNH2 protein (19): ESI-QTOF MS, found: 26522.2, calcd for 
M (C1212H1873N306O334S14) 26523.1 (average). C-Terminally biotin-peptide-modified protein 
(21): ESI-QTOF MS, found: 30269.1, calcd for M (C1386H2135N355O376S15) 30268.5 (average). 
 
Figure S4. SDS-page analysis of protein samples followed by CBB strain: Lane 1: standard; Lanes 2 and 4: tagged 






7-3. Application to the C-terminally-CysProLeu-tagged DsRED-express protein (S8) 
Recombinant DsRED-express protein (S8) (14.5 nmol) was incubated in 266 μL (55 μM) of 
aqueous solution containing 1.2 μM CPY, 0.2 M NH2NH2·H2O, 60 mM cyclohexanone (pH 6.4) 
at 25 ˚C for 1 h. The reaction mixture was quenched with 266 μL of 50 mM Na phosphate 
containing 200 mM DTT, 200 mM MeONH2·HCl. The mixture was incubated at 25 ˚C for 10 
min and then buffer-exchanged, by use of a centrifugal filter equipped with a 10 kDa molecular 
weight cut off, into 50 mM Na phosphate (pH 6.8, 150 μL) by repeated dilution/concentration 
about 10 times. A part of the protein mixture (3.0 nmol, 53 μL) was mixed with 40 μL of 50 
mM Na phosphate containing 6 M Gn·HCl and the pH was adjusted to 3.0 with 1 M HCl aq.. 
To the mixture, 10 μL of 1.48 mM NaNO2 aq. was added at 4 ˚C and the reaction mixture was 
stored at 4 ˚C for 30 min. Then biotinylated N-terminal Cys peptide (20) (96.3 nmol) in 50 μL 
of 50 mM Na phosphate containing 6 M Gn·HCl and 30 mM MPAA was added to the reaction 
mixture and the mixture was incubated at room temperature. After that the crude protein was 
obtained by trichloroacetic acid (TCA) precipitation to remove small molecules and analyzed 
by SDS-PAGE (CBB stain and Western blot analysis using streptavidin-HRP). The conversion 
yield was estimated by quantitation of the ligated protein from CBB-stained gel image using 
imageJ software (Figure S5). 
 
 
Figure S5. (A) Scheme for the application of CPY-mediated protocol to C-terminally CysProLeu-OH-tagged 
recombinant DsRED-express protein (S8); (B) SDS-page analysis of protein samples: Lane 1: DsRED-express 
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